Skip to content
OpenCapital
Get started

Xenetic Biosciences XBIO Q3 2025 earnings

Reported November 12, 2025 · Before market open

Revenue$1.0MBeat by $397.0K
EPS-$0.33Beat by $0.16
Revenue estimate$630.0K
EPS estimate-$0.49

Next report

Aug 7, 2026 (In 1 week)

Versus estimates

Revenue

Q1 2026$806.9KQ4 2025$766.3KBeat by $76.3K
Q3 2025$1.0MBeat by $397.0K
Q2 2025$589.9KBeat by $110.9KQ1 2025$593.3KBeat by $77.3KQ4 2024$648.8K

Diluted EPS

Q1 2026-$0.20Q4 2025-$0.22Beat by $0.30
Q3 2025-$0.33Beat by $0.16
Q2 2025-$0.45Beat by $0.19Q1 2025-$0.59Beat by $0.13Q4 2024-$0.68

Ask the moment Xenetic Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Xenetic Biosciences report Q3 2025 earnings?
Xenetic Biosciences (XBIO) reported Q3 2025 earnings on November 12, 2025 before market open.
What were Xenetic Biosciences's Q3 2025 revenue and EPS?
Xenetic Biosciences reported revenue of $1.0M and eps of $-0.33 for Q3 2025.
Did Xenetic Biosciences beat estimates in Q3 2025?
Revenue beat the consensus estimate of $630.0K by $397.0K. EPS beat the consensus estimate of $-0.49 by $0.16.
How did Xenetic Biosciences's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 67.2% from $614.2K a year earlier and eps declined 17.9% from $-0.28.
Where can I find Xenetic Biosciences's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001683168-25-008288) and the 10-Q periodic report (0001683168-25-008259) directly on SEC EDGAR. The filing index links above go to sec.gov.